The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Every regulatory agency around the world has been addressing the emergent issues for the last two years and they may evolve through the lessons learned from the unprecedent situation…
Recently, as the number of approved Regenerative Medical Products (RMPs) in Japan has been rising, companies are expected to face a number of challenges specific to the Cell Therapy and/or Gene Therapy Products…